Louis Champel
Director/Board Member presso VETOQUINOL SA
Profilo
Louis Champel is an Independent Director at Vétoquinol SA since 2009.
Prior to this, he was the Chief Executive Officer at Rhone Merieux.
He also served as the Chairman & Chief Executive Officer at Merial SAS from 1997 to 2000.
From 2002 to 2008, he was the Managing Director at Lyon 3 Valorisation.
Mr. Champel completed his undergraduate degree at Sciences Po.
Posizioni attive di Louis Champel
| Società | Posizione | Inizio |
|---|---|---|
| VETOQUINOL SA | Director/Board Member | 22/09/2010 |
Precedenti posizioni note di Louis Champel
| Società | Posizione | Fine |
|---|---|---|
| Lyon 3 Valorisation | Chief Executive Officer | 01/01/2008 |
Merial SAS
 Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Chief Executive Officer | 01/01/2000 |
Rhone Merieux
 Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Chief Executive Officer | - |
Formazione di Louis Champel
| Sciences Po | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VETOQUINOL SA | Health Technology |
| Aziende private | 3 |
|---|---|
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Process Industries |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Health Technology |
| Lyon 3 Valorisation |
- Borsa valori
- Insiders
- Louis Champel
